As of Feb 20, 2025, LifeStance Health Group, Inc. Intrinsic Value is $4.3. This suggests it may be overvalued by 45.6% compared to its current price of around $7.9.
As of Feb 20, 2025, LifeStance Health Group, Inc.'s Discounted Cash Flow (DCF) valuation estimates its share price at N/A. This suggests it may be overvalued by N/A to its current price of around $7.9, using a discount rate of 8.9% and terminal growth rate of 3.0%.
LifeStance Health Group, Inc. is currently considered overvalued based on its Discounted Cash Flow (DCF) valuation and Relative Valuation, which estimates its share price to be $4.3, compared to a market price of around $7.9. This suggests a potential overvaluation of 45.6%.